Icecure Medical Ltd. current report, Q4 FY2021

Business Context and Reporting Period

Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 2021 (Specifically December 13, 2021)
Context: The filing reports the closing of a capital raising event via an underwritten public offering.

Key Financial Metrics

Capital Raised: $17 million (including partial exercise of over-allotment option).
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics. This document serves solely to announce the financing transaction.

Material Changes

The primary material change reported is the successful completion of a $17 million underwritten public offering, which includes the partial exercise of an over-allotment option. This represents a significant increase in the company's cash resources compared to the immediate prior period.

Guidance, Outlook, and Risks

Management Commentary: The filing references a press release confirming the closing of the offering but does not include detailed management commentary, forward-looking guidance, or specific risk factors within the text provided.
Unusual Items: None reported beyond the standard execution of the public offering.

Investor Verification Checklist

  • Verify the final number of shares issued and the price per share in the full press release (Exhibit 99.1).
  • Confirm the specific portion of the $17 million attributable to the over-allotment option versus the base offering.
  • Review the company's latest Form 20-F for updated cash balance and burn rate post-offering.
  • Check for any dilution impact on existing shareholders resulting from this issuance.